摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N'-Isopropyl-morpholine-N-carboxamide | 50708-02-6

中文名称
——
中文别名
——
英文名称
N'-Isopropyl-morpholine-N-carboxamide
英文别名
morpholine-4-carboxylic acid isopropylamide;N'-isopropylmorpholine-N-carboxamide;N-(N'-Isopropylcarbamoyl)-morpholin;N-(Isopropylcarbamoyl)-morpholin;4-Morpholinecarboxamide, N-(1-methylethyl)-;N-propan-2-ylmorpholine-4-carboxamide
N'-Isopropyl-morpholine-N-carboxamide化学式
CAS
50708-02-6
化学式
C8H16N2O2
mdl
MFCD02859868
分子量
172.227
InChiKey
VGEHUCHOIFQYFR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    352.2±31.0 °C(Predicted)
  • 密度:
    1.062±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.875
  • 拓扑面积:
    41.6
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:1122027050994c865ae5ab8c541eda16
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    吗啉异氰酸异丙酯二氯甲烷 为溶剂, 反应 2.0h, 以98%的产率得到N'-Isopropyl-morpholine-N-carboxamide
    参考文献:
    名称:
    ROMPGEL Scavengers:  A High-Loading Supported Anhydride for Sequestering Amines and Hydrazines
    摘要:
    [GRAPHICS]A versatile method for sequestering excess amines and hydrazines is reported using a high loading ROMPGEL anhydride polymer.
    DOI:
    10.1021/ol006191s
点击查看最新优质反应信息

文献信息

  • [EN] AMINO - PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBKL AND/OR IKK EPSILON<br/>[FR] COMPOSÉS D'AMINO-PYRIMIDINE EN TANT QU'INHIBITEURS DE TBKL ET OU D'IKK EPSILON
    申请人:MYREXIS INC
    公开号:WO2011046970A1
    公开(公告)日:2011-04-21
    The invention relates to certain amino-pyrimidine compounds which inhibit TBK1 and/or IKK epsilon and which may therefore find application in treating inflammation, cancer, septic shock and/or Primary open Angle Glaucoma (POAG).
    这项发明涉及抑制TBK1和/或IKK epsilon的某些氨基嘧啶化合物,因此可能在治疗炎症、癌症、感染性休克和/或原发性开角青光眼(POAG)中找到应用。
  • CDK INHIBITORS AND THEIR USE AS PHARMACEUTICALS
    申请人:Prelude Therapeutics Incorporated
    公开号:US20210070761A1
    公开(公告)日:2021-03-11
    The disclosure is directed to, in part, to CDK inhibitors, pharmaceutical compositions comprising the same, as well as methods of their use and preparation.
    该披露部分涉及CDK抑制剂,包含相同物质的药物组合物,以及它们的使用和制备方法。
  • NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
    申请人:Gopalan Balasubramanian
    公开号:US20090182143A1
    公开(公告)日:2009-07-16
    The present invention relates to novel heterocyclic compounds, their analogs, their tautomers, their regioisomers, their stereoisomers, their enantiomers, their diastereomers, their polymorphs, their pharmaceutically acceptable salts, their appropriate N-oxides, their pharmaceutically acceptable solvates and their pharmaceutical compositions containing them. The present invention more particularly relates to novel Phosphodiesterase type 4 (PDE4) inhibitors of the Formula (1), their analogs, tautomers, enantiomers, diasteromers, regioisomers, stereoisomers, polymorphs, pharmaceutically acceptable salts, appropriate N-oxide, pharmaceutically acceptable solvates and the pharmaceutical compositions containing them.
    本发明涉及新型杂环化合物、它们的类似物、互变异构体、位置异构体、立体异构体、对映异构体、顺反异构体、多晶型、药学上可接受的盐、适当的N-氧化物、药学上可接受的溶剂和含有它们的制药组合物。本发明更特别地涉及式(1)的新型磷酸二酯酶4(PDE4)抑制剂、它们的类似物、互变异构体、对映异构体、顺反异构体、位置异构体、立体异构体、多晶型、药学上可接受的盐、适当的N-氧化物、药学上可接受的溶剂和含有它们的制药组合物。
  • N-Aminosulfenyl carbamate compounds, compositions and use
    申请人:Union Carbide Corporation
    公开号:US04315928A1
    公开(公告)日:1982-02-16
    A novel class of N-aminosulfenyl carbamate compositions have outstanding insecticidal and miticidal properties coupled with very low toxicity to mammals and important economic crops.
    一种新型的N-酰基氨基甲酸酯组合物具有优异的杀虫和杀螨性能,同时对哺乳动物和重要经济作物的毒性非常低。
  • AMINO-PYRIMIDINE COMPOUNDS AS INHIBITORS OF IKK EPSILON AND/OR TBK1
    申请人:HOLCOMB Ryan C.
    公开号:US20120238540A1
    公开(公告)日:2012-09-20
    The invention relates to certain amino-pyrimidine compounds that inhibit IKK epsilon and/or TBK1, methods of making such compounds, pharmaceutical compositions comprising such compounds, and the use of these compounds in treating a variety of diseases and disorders.
    本发明涉及一些氨基嘧啶化合物,可抑制IKK epsilon和/或TBK1,制备这种化合物的方法,包含这种化合物的药物组合物,以及在治疗各种疾病和疾病失调中使用这些化合物的方法。
查看更多